Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune study

BACKGROUND: Immunotherapy alone or in combination has clearly improved the survival of patients with lung cancer. However, it may also be responsible for adverse events impacting these patients' quality of life. The ToxImmune study aims to identify prognostic factors that can help to predict im...

Descripción completa

Detalles Bibliográficos
Autores principales: Difoum, Francoise, Schernberg, Antoine, Vanquaethem, Hélène, Picchi, Hugo, Roy, Audrey Le, Vuagnat, Perrine, Helissey, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363797/
https://www.ncbi.nlm.nih.gov/pubmed/36494190
http://dx.doi.org/10.1002/cnr2.1760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363797/
https://www.ncbi.nlm.nih.gov/pubmed/36494190
http://dx.doi.org/10.1002/cnr2.1760

Ejemplares similares